PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30392131-3	2019	METHODS: Sprague-Dawley rats were used to assess the differential effects of SCH 442416 and istradefylline that antagonize presynaptic and postsynaptic A2AR, respectively.	istradefylline	92-106	adenosine A2a receptor	Rattus norvegicus	152-156	
31408967-6	2019	The administration of istradefylline (a clinically approved A2AR antagonist) reduced deafferentation of inner hair cells and improved the survival of afferent synapses after excitotoxic injury.	istradefylline	22-36	adenosine A2a receptor	Rattus norvegicus	60-64	
24747180-5	2014	Therefore in this work we aimed to evaluate the impact of a chronic in vivo oral administration of an A2AR antagonist (KW-6002) in the BDNF actions upon hippocampal CA1 LTP.	istradefylline	119-126	adenosine A2a receptor	Rattus norvegicus	102-106	
24488405-0	2014	Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.	istradefylline	66-80	adenosine A2a receptor	Rattus norvegicus	31-53	
24488405-0	2014	Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.	istradefylline	82-89	adenosine A2a receptor	Rattus norvegicus	31-53	
12614340-0	2003	Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia.	istradefylline	74-81	adenosine A2a receptor	Rattus norvegicus	40-62	
11090641-0	2000	Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats.	istradefylline	49-56	adenosine A2a receptor	Rattus norvegicus	0-24